Hub : Traits :

Irritability

628 significantly associated models · 84 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	2	43899918	45698128	1	1	8.9e-08	3.3e-08	1.0e-01	91	CAMKMT
2	3	48350366	50144951	8	1	2.7e-09	6.1e-09	1.0e+00	100	CCDC36
3	5	49462228	50836718	2	1	6.4e-08	9.3e-07	1.2e-01	90	PARP8
4	5	87104604	88677293	1	1	3.7e-08	6.8e-10	5.3e-03	80	LINC00461
5	7	11553163	12967449	1	1	1.7e-07	6.0e-08	1.4e-01	93	TMEM106B
6	8	8092025	13120332	35	1	6.9e-17	1.0e-17	6.5e-05	78	AF131215.9
7	8	88801153	89582625	1	1	1.5e-08	4.4e-11	7.4e-04	74	MMP16
8	12	15807367	17456908	1	1	7.8e-08	4.6e-05	3.6e-02	74	MGST1
9	13	110831451	112257226	1	1	1.5e-07	4.6e-06	1.0e+00	100	ANKRD10
10	16	30347731	31758245	6	1	3.6e-10	3.8e-10	2.3e-01	96	HSD3B7
11	16	70624483	72022941	2	1	2.9e-08	7.9e-08	1.3e-01	92	CMTR2
12	17	42774693	45796313	18	1	1.3e-11	1.4e-09	3.5e-01	98	WNT3
13	20	32254831	34109427	4	1	2.1e-13	7.1e-12	8.3e-01	100	TP53INP2
14	22	40472399	42379813	2	1	9.1e-08	7.0e-09	2.5e-02	85	SLC25A17

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Tanning	17.06	1	1	2.2	0.00	1.0e+00	TP53INP2
Neuroticism score	15.25	9	6	13.3	0.98	3.1e-06	AF131215.9 ANKRD10 HSD3B7 LINC00461 PARP8 SLC25A17 TMEM106B TP53INP2 WNT3
Neuroticism (Nagel 2018)	13.35	9	6	13.3	0.98	2.5e-06	ANKRD10 CMTR2 HSD3B7 LINC00461 PARP8 SLC25A17 TMEM106B TP53INP2 WNT3
Mood swings	11.82	6	4	8.9	1.00	2.9e-05	AF131215.9 CMTR2 HSD3B7 SLC25A17 TMEM106B WNT3
Neuroticism	11.33	8	5	11.1	0.98	2.4e-05	CMTR2 HSD3B7 LINC00461 PARP8 SLC25A17 TMEM106B TP53INP2 WNT3
Depressed Affect (Nagel 2018)	10.45	7	4	8.9	0.99	4.7e-05	CCDC36 CMTR2 HSD3B7 LINC00461 PARP8 TMEM106B WNT3
Tense / 'highly strung'	9.85	5	2	4.4	0.99	8.8e-04	AF131215.9 HSD3B7 SLC25A17 TMEM106B TP53INP2
Neuroticism (2016)	9.55	4	2	4.4	1.00	1.5e-03	AF131215.9 LINC00461 SLC25A17 WNT3
Worrier / anxious feelings	8.96	4	3	6.7	0.98	2.4e-02	AF131215.9 HSD3B7 SLC25A17 WNT3
Hair Pigment	8.85	3	2	4.4	0.00	1.0e+00	SLC25A17 TP53INP2 WNT3
Nervous feelings	8.39	4	2	4.4	0.98	1.6e-02	AF131215.9 SLC25A17 TP53INP2 WNT3
Sensitivity / hurt feelings	8.20	2	2	4.4	0.00	1.0e+00	AF131215.9 WNT3
Fed-up feelings	7.81	6	2	4.4	0.99	4.6e-05	AF131215.9 ANKRD10 CMTR2 LINC00461 PARP8 WNT3
Hair/balding pattern: Pattern 4	7.69	1	1	2.2	0.00	1.0e+00	WNT3
Worry (Nagel 2018)	7.57	5	2	4.4	0.99	9.1e-04	HSD3B7 SLC25A17 TMEM106B TP53INP2 WNT3
Miserableness	7.35	3	3	6.7	0.00	1.0e+00	AF131215.9 TMEM106B WNT3
Worry too long after embarrassment	6.64	5	1	2.2	0.99	9.2e-04	AF131215.9 ANKRD10 LINC00461 TP53INP2 WNT3
Frequency of tenseness / restlessness in last 2 weeks	6.62	2	1	2.2	0.00	1.0e+00	TMEM106B WNT3
Hair/balding pattern: Pattern 3	6.14	1	1	2.2	0.00	1.0e+00	WNT3
Relative age of first facial hair	5.70	1	1	2.2	0.00	1.0e+00	WNT3
Frequency of depressed mood in last 2 weeks	5.63	3	0	0.0	0.00	1.0e+00	AF131215.9 TMEM106B WNT3
Blood Red Count	5.53	5	3	6.7	0.81	9.8e-02	ANKRD10 CMTR2 HSD3B7 LINC00461 WNT3
Guilty feelings	5.48	2	1	2.2	0.00	1.0e+00	AF131215.9 WNT3
Impedance of whole body	5.34	6	6	13.3	0.21	6.9e-01	AF131215.9 CCDC36 LINC00461 MMP16 TP53INP2 WNT3
Forced expiratory volume in 1-second (FEV1)	5.28	2	2	4.4	0.00	1.0e+00	HSD3B7 WNT3
Loneliness, isolation	5.26	2	0	0.0	0.00	1.0e+00	TMEM106B WNT3
Forced expiratory volume in 1-second (FEV1), Best measure	5.24	2	2	4.4	0.00	1.0e+00	HSD3B7 WNT3
Lung FVC	5.19	3	3	6.7	0.00	1.0e+00	HSD3B7 TP53INP2 WNT3
Depression (Nagel 2018)	5.18	3	1	2.2	0.00	1.0e+00	CMTR2 TMEM106B WNT3
Seen doctor (GP) for nerves, anxiety, tension or depression	5.12	1	1	2.2	0.00	1.0e+00	TMEM106B
Impedance of leg (left)	5.02	5	4	8.9	0.51	3.8e-01	AF131215.9 LINC00461 MMP16 TP53INP2 WNT3
Heel bone mineral density (BMD) T-score, automated (right)	4.99	3	2	4.4	0.00	1.0e+00	AF131215.9 CCDC36 MMP16
Forced vital capacity (FVC), Best measure	4.98	2	2	4.4	0.00	1.0e+00	HSD3B7 WNT3
Relative age voice broke	4.88	1	1	2.2	0.00	1.0e+00	WNT3
Impedance of arm (right)	4.83	7	5	11.1	0.10	8.3e-01	AF131215.9 CCDC36 LINC00461 MMP16 TMEM106B TP53INP2 WNT3
Suffer from 'nerves'	4.80	2	1	2.2	0.00	1.0e+00	AF131215.9 WNT3
Forced vital capacity (FVC)	4.78	2	2	4.4	0.00	1.0e+00	HSD3B7 WNT3
Heel bone mineral density (BMD) T-score, automated (left)	4.74	2	1	2.2	0.00	1.0e+00	AF131215.9 CCDC36
Impedance of arm (left)	4.70	6	4	8.9	0.11	8.4e-01	AF131215.9 CCDC36 MMP16 TMEM106B TP53INP2 WNT3
Impedance of leg (right)	4.68	4	4	8.9	0.67	3.3e-01	AF131215.9 LINC00461 MMP16 TP53INP2
Forced expiratory volume in 1-second (FEV1), predicted percentage	4.55	2	2	4.4	0.00	1.0e+00	HSD3B7 WNT3
Frequency of tiredness / lethargy in last 2 weeks	4.40	2	1	2.2	0.00	1.0e+00	CCDC36 TMEM106B
Peak expiratory flow (PEF)	4.12	3	1	2.2	0.00	1.0e+00	AF131215.9 CAMKMT WNT3
Sitting height	4.06	3	3	6.7	0.00	1.0e+00	CAMKMT TP53INP2 WNT3
Headache pain in last month	4.05	1	1	2.2	0.00	1.0e+00	WNT3
Hand grip strength (left)	3.89	3	1	2.2	0.00	1.0e+00	CAMKMT MMP16 WNT3
Seen a psychiatrist for nerves, anxiety, tension or depression	3.80	1	0	0.0	0.00	1.0e+00	TMEM106B
Mouth/teeth dental problems: Mouth ulcers	3.75	1	1	2.2	0.00	1.0e+00	WNT3
Medication: Paracetamol	3.67	1	1	2.2	0.00	1.0e+00	WNT3
Hip circumference	3.64	5	4	8.9	-0.44	4.6e-01	AF131215.9 HSD3B7 LINC00461 MMP16 TP53INP2
Body mass index (BMI)	3.63	4	2	4.4	-0.38	6.2e-01	AF131215.9 HSD3B7 LINC00461 MMP16
Time employed in main current job	3.43	1	1	2.2	0.00	1.0e+00	WNT3
Leg predicted mass (left)	3.39	5	4	8.9	-0.71	1.8e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Medication: Paracetamol	3.39	1	1	2.2	0.00	1.0e+00	WNT3
Leg fat-free mass (left)	3.38	5	4	8.9	-0.71	1.8e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Arm predicted mass (right)	3.38	5	3	6.7	-0.77	1.3e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Arm predicted mass (left)	3.38	5	3	6.7	-0.77	1.3e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Arm fat-free mass (right)	3.37	5	3	6.7	-0.76	1.4e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Medication for pain relief, constipation, heartburn	3.35	1	1	2.2	0.00	1.0e+00	WNT3
Leg fat-free mass (right)	3.35	5	4	8.9	-0.74	1.5e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Leg predicted mass (right)	3.35	5	4	8.9	-0.74	1.5e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Trunk fat percentage	3.34	5	2	4.4	-0.32	6.0e-01	CCDC36 HSD3B7 LINC00461 SLC25A17 WNT3
Depression (self-reported)	3.34	1	0	0.0	0.00	1.0e+00	TMEM106B
Trunk fat mass	3.32	3	2	4.4	0.00	1.0e+00	HSD3B7 LINC00461 WNT3
Handedness (chirality/laterality): Left-handed	3.30	1	1	2.2	0.00	1.0e+00	WNT3
Arm fat mass (left)	3.30	3	2	4.4	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Arm fat mass (right)	3.29	3	2	4.4	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Age at first live birth	3.29	1	0	0.0	0.00	1.0e+00	AF131215.9
Weight	3.22	5	3	6.7	-0.45	4.4e-01	AF131215.9 CAMKMT HSD3B7 LINC00461 TP53INP2
Arm fat-free mass (left)	3.18	5	3	6.7	-0.76	1.3e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Comparative body size at age 10	3.17	5	1	2.2	-0.47	4.2e-01	AF131215.9 CAMKMT HSD3B7 LINC00461 TP53INP2
Whole body fat mass	3.16	3	1	2.2	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Leg fat mass (right)	3.16	3	2	4.4	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Leg fat mass (left)	3.16	3	2	4.4	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Basal metabolic rate	3.14	5	5	11.1	-0.73	1.6e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Whole body water mass	3.11	5	4	8.9	-0.77	1.3e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Whole body fat-free mass	3.08	5	4	8.9	-0.77	1.3e-01	AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Arm fat percentage (left)	3.07	3	1	2.2	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Hair/balding pattern: Pattern 2	3.06	1	1	2.2	0.00	1.0e+00	WNT3
High blood pressure (siblings)	2.99	1	0	0.0	0.00	1.0e+00	TMEM106B
Triglycerides	2.98	1	0	0.0	0.00	1.0e+00	TP53INP2
Body fat percentage	2.98	3	1	2.2	0.00	1.0e+00	HSD3B7 LINC00461 WNT3
Number of full brothers	2.95	1	0	0.0	0.00	1.0e+00	WNT3
Fractured/broken bones in last 5 years	2.93	1	0	0.0	0.00	1.0e+00	WNT3
Major Depression (MDD)	2.92	1	0	0.0	0.00	1.0e+00	TMEM106B
Alcohol intake frequency.	2.92	1	1	2.2	0.00	1.0e+00	WNT3
High blood pressure	2.90	2	1	2.2	0.00	1.0e+00	AF131215.9 CCDC36
BMI	2.89	3	1	2.2	0.00	1.0e+00	HSD3B7 LINC00461 MMP16
Mean Putamen Volume	2.88	1	0	0.0	0.00	1.0e+00	WNT3
Waist Hip Ratio (WHR)	2.85	2	2	4.4	0.00	1.0e+00	MMP16 WNT3
Trunk predicted mass	2.85	4	3	6.7	-0.95	5.3e-02	AF131215.9 CAMKMT MMP16 TP53INP2
Hypertension (Self-reported)	2.85	2	1	2.2	0.00	1.0e+00	AF131215.9 CCDC36
Trunk fat-free mass	2.79	4	3	6.7	-0.95	5.1e-02	AF131215.9 CAMKMT MMP16 TP53INP2
Average weekly beer plus cider intake	2.79	1	0	0.0	0.00	1.0e+00	AF131215.9
Hand grip strength (right)	2.78	2	1	2.2	0.00	1.0e+00	CAMKMT WNT3
Emphysema/chronic bronchitis	2.77	1	0	0.0	0.00	1.0e+00	WNT3
Arm fat percentage (right)	2.75	3	1	2.2	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Medication: Bendroflumethiazide	2.74	1	1	2.2	0.00	1.0e+00	AF131215.9
Schizophrenia (2018)	2.69	1	0	0.0	0.00	1.0e+00	SLC25A17
Systolic blood pressure, automated reading	2.68	2	1	2.2	0.00	1.0e+00	AF131215.9 CCDC36
Ever unenthusiastic/disinterested for a whole week	2.68	1	0	0.0	0.00	1.0e+00	WNT3
Bipolar Disorder or Schizophrenia	2.65	1	1	2.2	0.00	1.0e+00	SLC25A17
Qualifications: College or University degree	2.64	2	2	4.4	0.00	1.0e+00	LINC00461 WNT3
Vascular/heart problems diagnosed by doctor	2.60	2	1	2.2	0.00	1.0e+00	AF131215.9 CCDC36
Risk taking	2.59	1	0	0.0	0.00	1.0e+00	AF131215.9
Diastolic blood pressure, automated reading	2.59	2	2	4.4	0.00	1.0e+00	AF131215.9 LINC00461
Schizophrenia (2014)	2.58	1	0	0.0	0.00	1.0e+00	SLC25A17
Current tobacco smoking	2.56	1	0	0.0	0.00	1.0e+00	SLC25A17
Smoking Status	2.52	2	0	0.0	0.00	1.0e+00	CCDC36 WNT3
Deep venous thrombosis (DVT) (self-reported)	2.50	1	0	0.0	0.00	1.0e+00	TP53INP2
Intelligence (Savage-Jansen 2018)	2.49	2	2	4.4	0.00	1.0e+00	LINC00461 WNT3
Leg fat percentage (right)	2.49	2	2	4.4	0.00	1.0e+00	HSD3B7 LINC00461
Basal cell carcinoma (self-reported)	2.45	1	0	0.0	0.00	1.0e+00	TP53INP2
Leg fat percentage (left)	2.44	3	1	2.2	0.00	1.0e+00	AF131215.9 HSD3B7 LINC00461
Heel T-Score	2.43	4	3	6.7	-0.78	2.2e-01	CCDC36 MMP16 SLC25A17 WNT3
Medication: Blood pressure	2.41	1	0	0.0	0.00	1.0e+00	AF131215.9
Waist circumference	2.38	2	1	2.2	0.00	1.0e+00	HSD3B7 LINC00461
Past tobacco smoking	2.37	1	0	0.0	0.00	1.0e+00	WNT3
Ovarian Cancer	2.35	1	1	2.2	0.00	1.0e+00	WNT3
Neck or shoulder pain in last month	2.34	1	0	0.0	0.00	1.0e+00	CMTR2
Breast Cancer	2.31	1	1	2.2	0.00	1.0e+00	WNT3
Mouth/teeth dental problems	2.30	1	0	0.0	0.00	1.0e+00	WNT3
Blood clot in the leg (DVT)	2.29	1	0	0.0	0.00	1.0e+00	TP53INP2
Number of self-reported non-cancer illnesses	2.28	1	0	0.0	0.00	1.0e+00	TMEM106B
Average weekly champagne plus white wine intake	2.28	1	0	0.0	0.00	1.0e+00	WNT3
Pain experienced in last month	2.25	1	0	0.0	0.00	1.0e+00	WNT3
Standing height	2.22	4	3	6.7	-0.99	5.2e-03	CAMKMT TMEM106B TP53INP2 WNT3
Verbal and Numeric Reasoning (VNR)	2.19	1	0	0.0	0.00	1.0e+00	LINC00461
Leg pain on walking	2.17	1	0	0.0	0.00	1.0e+00	WNT3
Mouth/teeth dental problems: Dentures	2.16	1	0	0.0	0.00	1.0e+00	TP53INP2
Primary Biliary Cirrhosis	2.13	1	0	0.0	0.00	1.0e+00	WNT3
Supplements: Vitamin C	2.13	1	0	0.0	0.00	1.0e+00	WNT3
Hypothyroidism/myxoedema (self-reported)	2.11	1	1	2.2	0.00	1.0e+00	AF131215.9
Blood Eosinophil Count	2.07	3	3	6.7	0.00	1.0e+00	CCDC36 SLC25A17 WNT3
Pulse rate, automated reading	2.07	2	1	2.2	0.00	1.0e+00	CCDC36 LINC00461
Hearing difficulty/problems with background noise	2.06	1	0	0.0	0.00	1.0e+00	WNT3
Height	2.02	5	5	11.1	-0.79	1.1e-01	CAMKMT CMTR2 TMEM106B TP53INP2 WNT3
Comparative height size at age 10	2.02	4	2	4.4	-0.74	2.6e-01	CAMKMT CMTR2 TP53INP2 WNT3
High cholesterol (Self-reported)	2.02	1	0	0.0	0.00	1.0e+00	HSD3B7
Lupus	2.00	1	0	0.0	0.00	1.0e+00	AF131215.9
Qualifications: O levels/GCSEs or equivalent	1.92	1	0	0.0	0.00	1.0e+00	LINC00461
Age when periods started (menarche)	1.90	1	0	0.0	0.00	1.0e+00	CCDC36
Hearing difficulty/problems: Yes	1.88	1	0	0.0	0.00	1.0e+00	HSD3B7
Bipolar Disorder (2018)	1.78	1	0	0.0	0.00	1.0e+00	TP53INP2
Qualifications: A levels/AS levels or equivalent	1.77	1	0	0.0	0.00	1.0e+00	LINC00461
Illnesses of father: Heart disease	1.77	1	0	0.0	0.00	1.0e+00	WNT3
Number of live births	1.74	1	0	0.0	0.00	1.0e+00	WNT3
Allergy or Eczema	1.62	1	1	2.2	0.00	1.0e+00	SLC25A17
Forced expiratory volume in 1-second (FEV1), predicted	1.62	1	1	2.2	0.00	1.0e+00	TP53INP2
LDL Cholesterol	1.61	1	0	0.0	0.00	1.0e+00	CMTR2
Pulse rate	1.58	1	0	0.0	0.00	1.0e+00	CCDC36
Cholesterol lowering medication	1.57	1	0	0.0	0.00	1.0e+00	HSD3B7
Medication: Levothyroxine sodium	1.53	1	0	0.0	0.00	1.0e+00	AF131215.9
Qualifications: CSEs or equivalent	1.51	1	0	0.0	0.00	1.0e+00	WNT3
Lung FEV1/FVC ratio	1.33	1	0	0.0	0.00	1.0e+00	MMP16
Systolic Blood Pressure	0.96	1	0	0.0	0.00	1.0e+00	CMTR2
Blood Platelet Count	0.59	2	1	2.2	0.00	1.0e+00	LINC00461 WNT3
Blood White Count	0.55	2	0	0.0	0.00	1.0e+00	LINC00461 WNT3

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Small Intestine Terminal Ileum	6	1.302	2.1
GTEx	Uterus	9	1.587	2.1
GTEx	Cells EBV-transformed lymphocytes	11	0.773	2.0
GTEx	Artery Coronary	12	1.014	1.9
GTEx	Brain Cerebellar Hemisphere	8	0.537	1.9
GTEx	Brain Cortex	8	0.773	1.9
GTEx	Brain Frontal Cortex BA9	8	0.866	1.9
GTEx	Brain Putamen basal ganglia	4	0.641	1.9
GTEx	Esophagus Gastroesophageal Junction	12	0.830	1.9
GTEx	Ovary	8	0.881	1.9
GTEx	Vagina	6	0.945	1.9
ROSMAP	Brain Pre-frontal Cortex	22	0.501	1.9
The Cancer Genome Atlas	Esophageal Carcinoma	4	0.584	1.9
GTEx	Adrenal Gland	9	0.618	1.8
GTEx	Brain Caudate basal ganglia	5	0.543	1.8
GTEx	Brain Nucleus accumbens basal ganglia	8	0.925	1.8
GTEx	Breast Mammary Tissue (Female)	8	0.487	1.8
GTEx	Colon Sigmoid	11	0.752	1.8
GTEx	Colon Transverse	15	0.727	1.8
GTEx	Esophagus Mucosa	15	0.452	1.8
GTEx	Esophagus Muscularis	16	0.495	1.8
GTEx	Heart Atrial Appendage	9	0.570	1.8
GTEx	Heart Left Ventricle	9	0.588	1.8
GTEx	Liver	3	0.418	1.8
GTEx	Pancreas	13	0.797	1.8
GTEx	Pituitary	7	0.628	1.8
GTEx	Prostate	5	0.599	1.8
GTEx	Skin Not Sun Exposed Suprapubic	15	0.610	1.8
GTEx	Spleen	7	0.496	1.8
GTEx	Stomach	10	0.688	1.8
GTEx	Testis	17	0.539	1.8
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	5	0.377	1.8
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.187	1.8
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	3	0.591	1.8
GTEx	Adipose Subcutaneous	14	0.401	1.7
GTEx	Adipose Visceral Omentum	10	0.491	1.7
GTEx	Artery Aorta	17	0.571	1.7
GTEx	Artery Tibial	11	0.292	1.7
GTEx	Brain Cerebellum	8	0.404	1.7
GTEx	Brain Hippocampus	4	0.763	1.7
GTEx	Brain Hypothalamus	4	0.678	1.7
GTEx	Breast Mammary Tissue	10	0.507	1.7
GTEx	Cells Transformed fibroblasts	11	0.262	1.7
GTEx	Lung	15	0.522	1.7
GTEx	Muscle Skeletal	9	0.311	1.7
GTEx	Nerve Tibial	15	0.347	1.7
GTEx	Skin Sun Exposed Lower leg	17	0.467	1.7
GTEx	Thyroid	19	0.475	1.7
GTEx	Whole Blood	8	0.401	1.7
NTR	Blood	6	0.250	1.7
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	7	0.423	1.7
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	3	0.273	1.7
The Cancer Genome Atlas	Colon Adenocarcinoma	5	0.242	1.7
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	8	0.390	1.7
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	5	0.200	1.7
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	4	0.241	1.7
The Cancer Genome Atlas	Stomach Adenocarcinoma	6	0.356	1.7
The Cancer Genome Atlas	Testicular Germ Cell Tumors	3	0.235	1.7
GTEx	Breast Mammary Tissue (Male)	10	0.838	1.6
CommonMind	Brain Pre-frontal Cortex	8	0.149	1.6
The Cancer Genome Atlas	Breast Invasive Carcinoma	8	0.182	1.6
The Cancer Genome Atlas	Glioblastoma Multiforme	2	0.196	1.6
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	5	0.184	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	11	0.268	1.6
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	4	0.362	1.6
The Cancer Genome Atlas	Lung Adenocarcinoma	6	0.204	1.6
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	6	0.377	1.6
The Cancer Genome Atlas	Prostate Adenocarcinoma	11	0.238	1.6
The Cancer Genome Atlas	Rectum Adenocarcinoma	1	0.145	1.6
The Cancer Genome Atlas	Soft Tissue Sarcoma	2	0.187	1.6
The Cancer Genome Atlas	Thyroid Carcinoma	9	0.174	1.6
METSIM	Adipose	5	0.108	1.5
YFS	Blood	4	0.087	1.5
The Cancer Genome Atlas	Brain Lower Grade Glioma	8	0.186	1.5